5433222026-08-185433222026-08-182026-08-185433222026-08-18in-capmkt:FinancialYear1Member5433222026-08-18in-capmkt:FinancialYear2Member5433222026-08-18in-capmkt:FinancialYear3Member5433222026-08-182026-08-18in-capmkt:FinancialYear1Member5433222026-08-182026-08-18in-capmkt:FinancialYear2Member5433222026-08-182026-08-18in-capmkt:FinancialYear3Memberiso4217:INRxbrli:pure543322Alivus Life Sciences LimitedALIVUSNOTLISTEDINE03Q201024NewAcquisition (including agreement to acquire)true2026-08-1816:35:002026-08-18Alivus Life Sciences LimitedListed Entity (self)IQGEN-X Pharma Private Limited34800000-44100000-152600000falsefalsetruePharmaceuticalsIQGEN-X Pharma Private Limited provides a wider spectrum for the Company to offer a complete end-to-end solution to its customers in both API and CDMO space.NofalseDecember 6, 2026 or such date as may be agreed by the acquirer from the execution of the Share purchase Agreement (SPA), subject to fulfilment of Conditions Precedent in the SPA. The SPA provides that if the Condition Precedents are not met within the above said timelines from the execution, the sellers will enter into a Business Transfer Agreement with the Company whereby the entire business will be acquired by the Company from IQGEN-X Pharma Private Limited including the employees and assets.Cash91200000Cash912000000IQGEN-X Pharma Private Limited is a company incorporated under the Companies Act 2013 as a private limited company in Oct 2016. It is engaged in the business of formulation development of Oral Solids, Sterile Injectables and Ophthalmic solutions for regulated and semi regulated markets. 2025-2026348000002024-2025318000002023-202426800000India